Compare Indosat Tbk. (ISAT) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indosat Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indosat Tbk. trades at Rp2,430 (market cap 77.4T, 93.15M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indosat Tbk. is far larger — about 741.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ISAT | SCPI | |
|---|---|---|
Market Cap | 77.4T | 104.4B |
Volume | 93.15M | — |
Lot | 931.49K | — |
Turnover | 223.55B | — |
Average Price | 2,399.91 | — |
Value | 223.55B | — |
Indicative Equilibrium Price | 2,430 | — |
Indicative Equilibrium Volume | 38.19K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indosat Tbk.
Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.
Read more on ISAT →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
